Vaxart, Inc. Cash
Vaxart, Inc. (VXRT) had Cash of $66.86 million as of 2020-12-31, per its 10-Q filed 2021-05-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2021-05-06
- 2020-12-31: Cash $66.86M.
- 2020-09-30: Cash $33.44M.
- 2020-06-30: Cash $44.39M.
- 2020-03-31: Cash $29.86M.
| Period end | Cash |
|---|---|
| 2020-12-31 | $66.86M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $33.44M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $44.39M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $29.86M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $13.51M 10-K · filed 2021-02-25 |
| 2019-09-30 | $19.54M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $16.24M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $8.36M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $11.44M 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |